[go: up one dir, main page]

DK1651618T3 - 2-substituerede pyrimidiner - Google Patents

2-substituerede pyrimidiner

Info

Publication number
DK1651618T3
DK1651618T3 DK04741053T DK04741053T DK1651618T3 DK 1651618 T3 DK1651618 T3 DK 1651618T3 DK 04741053 T DK04741053 T DK 04741053T DK 04741053 T DK04741053 T DK 04741053T DK 1651618 T3 DK1651618 T3 DK 1651618T3
Authority
DK
Denmark
Prior art keywords
substituted pyrimidines
pyrimidines
substituted
Prior art date
Application number
DK04741053T
Other languages
English (en)
Inventor
Markus Gewehr
Bernd Mueller
Peter Schaefer
Frank Schieweck
Oliver Wagner
Reinhard Stierl
Ulrich Schoefl
Siegfried Strathmann
Maria Scherer
Anja Schwoegler
Thomas Grote
Wassilios Grammenos
I Blasco Jordi Tormo
Andreas Gypser
Joachim Rheinheimer
Carsten Blettner
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Application granted granted Critical
Publication of DK1651618T3 publication Critical patent/DK1651618T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK04741053T 2003-07-24 2004-07-15 2-substituerede pyrimidiner DK1651618T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10333857 2003-07-24
DE10357714 2003-12-09
PCT/EP2004/007877 WO2005012261A1 (de) 2003-07-24 2004-07-15 2-substituierte pyrimidine

Publications (1)

Publication Number Publication Date
DK1651618T3 true DK1651618T3 (da) 2007-05-14

Family

ID=34117367

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04741053T DK1651618T3 (da) 2003-07-24 2004-07-15 2-substituerede pyrimidiner

Country Status (30)

Country Link
US (1) US7375108B2 (da)
EP (1) EP1651618B1 (da)
JP (1) JP2006528603A (da)
KR (1) KR20060052857A (da)
AP (1) AP2157A (da)
AR (1) AR045100A1 (da)
AT (1) ATE350370T1 (da)
AU (1) AU2004261373B8 (da)
BR (1) BRPI0412891A (da)
CA (1) CA2532718A1 (da)
CO (1) CO5660292A2 (da)
CR (1) CR8184A (da)
CY (1) CY1106391T1 (da)
DE (1) DE502004002570D1 (da)
DK (1) DK1651618T3 (da)
EA (1) EA010566B1 (da)
EC (1) ECSP066278A (da)
ES (1) ES2279395T3 (da)
HR (1) HRP20070057T3 (da)
IL (1) IL172848A0 (da)
MA (1) MA27949A1 (da)
MX (1) MXPA06000038A (da)
NZ (1) NZ545103A (da)
PE (1) PE20050882A1 (da)
PL (1) PL1651618T3 (da)
PT (1) PT1651618E (da)
SI (1) SI1651618T1 (da)
TW (1) TW200516075A (da)
UY (1) UY28436A1 (da)
WO (1) WO2005012261A1 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080132522A1 (en) * 2004-07-14 2008-06-05 Basf Aktiengesellschaft 2-Substituted Pyrimidines, Method for Their Production and Their Use for Controlling Pathogenic Fungi
CL2007002231A1 (es) * 2006-08-02 2008-04-11 Basf Ag Uso de compuestos derivados de 5-(het) arilpirimidina para combatir hongos daninos; compuestos derivados de 5-(het) arilpirimidina; agente fungicida; y agente farmaceutico.
ES2568260T3 (es) * 2010-11-16 2016-04-28 Acetylon Pharmaceuticals, Inc. Compuestos de pirimidin hidroxi amida como inhibidores de proteína desacetilasa y métodos de uso de los mismos
ES2929576T3 (es) 2013-10-08 2022-11-30 Acetylon Pharmaceuticals Inc Combinaciones de inhibidores de histona deacetilasa 6 y el inhibidor de Her2 lapatinib para el uso en el tratamiento del cáncer de mama
WO2015054474A1 (en) 2013-10-10 2015-04-16 Acetylon Pharmaceuticals, Inc. Pyrimidine hydroxy amide compounds as histone deacetylase inhibitors
EP4137135B1 (en) 2013-10-24 2024-06-05 Mayo Foundation for Medical Education and Research Treatment of polycystic diseases with an hdac6 inhibitor
KR20160092018A (ko) 2013-12-03 2016-08-03 에이스틸론 파마수티컬스 인코포레이티드 히스톤 탈아세틸화효소 저해제 및 면역조절 약물의 조합
US9464073B2 (en) 2014-02-26 2016-10-11 Acetylon Pharmaceuticals, Inc. Pyrimidine hydroxy amide compounds as HDAC6 selective inhibitors
CN107205988A (zh) 2014-07-07 2017-09-26 埃斯泰隆制药公司 利用组蛋白脱乙酰酶抑制剂治疗白血病
AU2015356779A1 (en) 2014-12-05 2017-07-13 University of Modena and Reggio Emilia Combinations of histone deacetylase inhibitors and bendamustine for use in the treatment of lymphoma
US10272084B2 (en) 2015-06-01 2019-04-30 Regenacy Pharmaceuticals, Llc Histone deacetylase 6 selective inhibitors for the treatment of cisplatin-induced peripheral neuropathy
JP2019515909A (ja) 2016-04-19 2019-06-13 アセチロン ファーマシューティカルズ インコーポレイテッドAcetylon Pharmaceuticals,Inc. 慢性リンパ性白血病の治療を目的とするhdac阻害剤単独またはbtk阻害剤との配合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ20024041A3 (cs) 2000-06-13 2003-04-16 Basf Aktiengesellschaft Fungicidní 5-fenyl substituované 2-(kyanamino) pyrimidiny
JP4361736B2 (ja) 2001-03-15 2009-11-11 ビーエーエスエフ ソシエタス・ヨーロピア 5−フェニルピリミジン、その製造方法、製造のための中間体および有害な菌類を防除するための使用
PL371059A1 (en) 2001-11-19 2005-06-13 Basf Aktiengesellschaft 5-phenylpyrimidines, agents comprising the same, method for production and use thereof

Also Published As

Publication number Publication date
PT1651618E (pt) 2007-03-30
JP2006528603A (ja) 2006-12-21
CR8184A (es) 2006-10-06
EP1651618B1 (de) 2007-01-03
CO5660292A2 (es) 2006-07-31
AP2006003497A0 (en) 2006-02-28
CA2532718A1 (en) 2005-02-10
KR20060052857A (ko) 2006-05-19
AR045100A1 (es) 2005-10-12
PL1651618T3 (pl) 2007-05-31
AU2004261373A1 (en) 2005-02-10
ECSP066278A (es) 2006-07-28
AU2004261373B8 (en) 2010-11-04
TW200516075A (en) 2005-05-16
PE20050882A1 (es) 2005-12-01
UY28436A1 (es) 2005-02-28
AU2004261373B2 (en) 2010-08-19
CY1106391T1 (el) 2011-10-12
WO2005012261A1 (de) 2005-02-10
ES2279395T3 (es) 2007-08-16
SI1651618T1 (sl) 2007-06-30
BRPI0412891A (pt) 2006-10-03
US7375108B2 (en) 2008-05-20
HRP20070057T3 (en) 2007-07-31
AP2157A (en) 2010-09-13
EA010566B1 (ru) 2008-10-30
US20070105873A1 (en) 2007-05-10
EA200600212A1 (ru) 2006-08-25
DE502004002570D1 (de) 2007-02-15
EP1651618A1 (de) 2006-05-03
MA27949A1 (fr) 2006-06-01
MXPA06000038A (es) 2006-03-21
IL172848A0 (en) 2006-06-11
ATE350370T1 (de) 2007-01-15
NZ545103A (en) 2008-06-30

Similar Documents

Publication Publication Date Title
EP1546115A4 (en) Substituted pyrimidines
DK1487805T3 (da) Pyrimidinderivater
ATE529412T1 (de) Herbizide pyrimidine
IS8006A (is) Setin pýrimidínón
EP1724267A4 (en) pyrimidine derivative
DE602004018654D1 (de) Se
DE602004024728D1 (de) Schiebeelement
MA28824B1 (fr) Derives de pyrimidine
DK1667992T3 (da) Quinazolinderivater
MA28813B1 (fr) Derives de pyrimidine
AT502792A5 (de) Düsenanpressvorrichtung
ATE356124T1 (de) Hydroxyalkylsubstituierte pyrido-7-pyrimidin-7- one
ATE366242T1 (de) 5-substituierte chinazolinonderivate
DK1651618T3 (da) 2-substituerede pyrimidiner
IS8015A (is) 6-útskipt imídasópýrasín
ATE444953T1 (de) Substituierte spirobenzazepine
DE60322439D1 (de) Anschlussstück
IL172845A0 (en) 2-substituted pyrimidines
ES1055359Y (es) Pieza de construccion
IS8444A (is) Staðgengin indól-o-glúkósíð
IS8443A (is) Staðgengin indasól-o-glúkósíð
SE0300751D0 (sv) Hjälpmedel
UA8109S (uk) Профіль
UA7811S (uk) Профіль
UA8504S (uk) Профіль